We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Tissue Sterilization Process Proven Effective

By HospiMedica staff writers
Posted on 17 Aug 2004
More than 540,000 implants sterilized with a patented tissue sterilization process called BioCleanse have been distributed with no incidence of graft-related infection.

Standard methods to prepare tissue for transplant include screening for diseases, bacterial testing, and aseptic processing, all of which help to reduce the risk to patients but are not sufficient to eliminate the risk of allograft-associated infections in recipients. More...
The BioCleanse method, developed and patented by Regeneration Technologies, Inc. (RTI, Alachua, FL, USA), is a proven tissue sterilization process, validated to eliminate viruses, bacteria, fungi, and spores from tissue without affecting the structural biomechanical integrity of the allograft.

RTI processes allograft tissue into shaped implants for use in orthopedic, cardiovascular, and other surgeries, enabling patients to benefit from the gift of donated tissues. "Donor families entrust us with their gift of donation because they know through our innovations, we will serve as responsible stewards of each gift by safely helping as many people as possible,” remarked Brian K. Hutchison, chairman, president, and CEO of RTI. The company was named a 2004 Technology Pioneer by the World Economic Forum.




Related Links:
RTI

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.